Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease

Blood (2021) 137 (17): 2403–2416.

https://doi.org/10.1182/blood.2020008720

Published: 2021

Includes: Supplemental data

Journal Articles

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Joachim Beck, MD, Monika Brueggemann, Thomas Burmeister, MD, Eike C. Buss, MD, Norbert Frickhofen, MD, Andreas Huettmann, MD, Anke Morgner, MD, Albrecht Reichle, Ingo Schmidt-Wolf, MD, Stefan Schwartz, MD, Hubert Serve, Prof. Dr. med., Bernd M Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Andreas Viardot, MD, Knut Wendelin, MD, Dieter Hoelzer, MD

Blood (2012) 120 (21): 1493.

https://doi.org/10.1182/blood.V120.21.1493.1493

Published: 2012

Journal Articles

Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease

Pawel Zerr, Katrin Palumbo-Zerr, Alfiya Distler, Michal Tomcik, Stefan Vollath, Luis E. Munoz, Christian Beyer, Clara Dees, Friederike Egberts, Ilaria Tinazzi, Francesco Del Galdo, Oliver Distler, Georg Schett, Bernd M. Spriewald, Jörg H. W. Distler

Blood (2012) 120 (14): 2909–2917.

https://doi.org/10.1182/blood-2012-01-403428

Published: 2012

Journal Articles

Monitoring of Hematopoietic Chimerism by Real-Time Quantitative PCR of Single Nucleotide Polymorphisms In Samples with Low DNA Quantities.

Christian Bach, Elmira Tomova, Katja Goldmann, Birgit Lauer, Wolf Roesler, Andreas Mackensen, MD, Julia Winkler, Bernd M Spriewald

Blood (2010) 116 (21): 3491.

https://doi.org/10.1182/blood.V116.21.3491.3491

Published: 2010

Journal Articles

Novel Anti-Fibrotic Therapies for Experimental Chronic Graft-Versus-Host Disease.

Bernd M. Spriewald, MD, Pawel Zerr, MSc, Alfiya Akhmetshina, PhD, Andreas Mackensen, MD, Georg Schett, MD, Joerg H.W. Distler, MD

Blood (2009) 114 (22): 4490.

https://doi.org/10.1182/blood.V114.22.4490.4490

Published: 2009

NARROW

Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease

Monitoring of Hematopoietic Chimerism by Real-Time Quantitative PCR of Single Nucleotide Polymorphisms In Samples with Low DNA Quantities.

Novel Anti-Fibrotic Therapies for Experimental Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Inhibition of hedgehog signaling for the treatment of murine sclerodermatous chronic graft-versus-host disease

Monitoring of Hematopoietic Chimerism by Real-Time Quantitative PCR of Single Nucleotide Polymorphisms In Samples with Low DNA Quantities.

Novel Anti-Fibrotic Therapies for Experimental Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only